ArticleThe American journal of emergency medicine2020
Weakness and elevated creatinine kinase as the initial presentation of coronavirus disease 2019 (COVID-19).
Article in The American journal of emergency medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
49 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis.BMJ evidence-based medicine · 2021Pooled it
- Neurological involvement of coronavirus disease 2019: a systematic review.Journal of neurology · 2020Pooled it
- The prognostic value of elevated creatine kinase to predict poor outcome in patients with COVID-19 - A systematic review and meta-analysis.Diabetes & metabolic syndromePooled it
- Bilateral Myositis Ossificans of the Deltoid Muscle Secondary to the COVID-19 Vaccine: A Case Report.Case reports in medicine · 2026Article
- SARS-CoV-2 animal vaccine with cross-protection against Wuhan strain and delta variant.Scientific reports · 2025Article
- Sinusoidal exponential distribution for modeling elevated creatinine kinase level as the initial presentation of Covid-19.Scientific reports · 2025Article
- Review
- Effectiveness of massage and range of motion exercises on muscle strength and intensive care unit-acquired weakness in Iranian patients with COVID-19: a randomized parallel-controlled trial.Acute and critical care · 2024Article
- Rhabdomyolysis secondary to COVID-19 infection and vaccination: a review of literature.Frontiers in medicine · 2024Review
- Muscle strength/intensive care unit acquired weakness in COVID-19 and non-COVID-19 patients.Nursing in critical care · 2023Article
- Understanding common population markers for SARS-CoV-2 RNA normalization in wastewater - A review.Chemosphere · 2023Review
- Analysis of altered level of blood-based biomarkers in prognosis of COVID-19 patients.PloS one · 2023Article
- Handgrip strength is associated with adverse outcomes in patients hospitalized for COVID-19-associated pneumonia.Internal and emergency medicine · 2022Article
- Skeletal Muscle Manifestations and Creatine Kinase in COVID-19.The Neurohospitalist · 2022Article
- Preliminary Guidelines for the Clinical Evaluation and Management of Long COVID.Infection & chemotherapy · 2022Review
- Electrochemical Biosensor for SARS-CoV-2 cDNA Detection Using AuPs-Modified 3D-Printed Graphene Electrodes.Biosensors · 2022Article
- Review
- Peripheral Neuropathy in Patients Recovering from Severe COVID-19: A Case Series.Medicina (Kaunas, Lithuania) · 2022Article
- Long COVID from rheumatology perspective - a narrative review.Clinical rheumatology · 2022Review
- The Musculoskeletal Involvement After Mild to Moderate COVID-19 Infection.Frontiers in physiology · 2022Review
Corrections and comments
- Commented on by
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
COVID-19 is a global public health emergency with more than one million positive cases across the globe. COVID-19 has a multifaceted presentation. We are herein to report two cases of SARS-CoV-2 induced rhabdomyolysis with an initial presentation of weakness and elevated creatinine kinase (CK). Both patients had no respiratory symptoms, they only complained of generalized weakness and were found to have elevated CK. Routine chest X-ray showed bilateral infiltrates in both cases and subsequently reverse-transcription polymerase chain reaction (RT-PCR) for SARS-CoV-2 was positive. To the best of our knowledge, there was only one literature to date documented SARS-CoV-2 induced rhabdomyolysis as a late complication of COVID-19 patient. Our cases showed that elevated CK and rhabdomyolysis can be the sole initial presentation of patients with COVID-19 and total CK should be ordered in every patient on admission.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.